Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S6 pseudogene 25 (RPS6P25) is a pseudogene in the human genome; it is a non-coding DNA segment similar in sequence to the functional ribosomal protein S6 gene but does not encode a functional protein product. Pseudogenes like RPS6P25 arise through duplication or retrotransposition of protein-coding genes and accumulate disabling mutations such as frameshifts or premature stop codons, which preclude translation into a functional protein. RPS6P25 is one among many ribosomal protein S6 pseudogenes dispersed throughout the genome, and there is no evidence for it acting as a therapeutic target, encoding a receptor, enzyme, or similar molecule. Such pseudogenes may play roles in gene regulation or genome evolution but do not have established drug interactions, biomarker utility, or known roles in disease pathophysiology[3][7][8][9]. Key supporting points: - RPS6P25 is listed as a pseudogene in all major genomic resources and does not encode a functional protein[8]. - There is no evidence to suggest it has a role as a therapeutic target, biomarker, or direct disease association[8][9]. - Aliases include RPS6_13_1629[7][8]. - No drugs interact with it, as it is not a functional protein or conventional molecular target. No incorrectness is detected in spelling or definition, but it should be emphasized this is not a classical drug target due to its pseudogene status[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S6 pseudogene 25 (RPS6P25).